MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2023 International Congress

    Monoamine loss and depression in Parkinson’s disease: a PET study

    BL. Xu, XL. Liu, SY. Liu, O. Barret, G. Tamagnan, H. Qiao, TB. Song, J. Lu, P. Chan (Beijing, China)

    Objective: 1)To evaluate the imaging manifestations of monoamine changes in PD patients with depression through 18F-FP-DTBZ PET; 2) To explore the relationship between monoamine changes…
  • 2023 International Congress

    Longitudinal assessment of evolution and plasma biomarkers for depression and anxiety in Parkinson’s disease

    J. Lin, R. Ou, C. Li, Q. Wei, Y. Hou, L. Zhang, K. Liu, Q. Jiang, T. Yang, Y. Xiao, D. Pang, Y. Yu, B. Zhao, X. Chen, W. Song, J. Yang, Y. Wu, H. Shang (Chengdu, China)

    Objective: We aimed to investigatethe evolution of depression and anxietyin a large Parkinson's disease (PD) cohort and explore the related plasma biomarkers. Background: Depression and anxietyare common non-motor…
  • 2023 International Congress

    Hazard ratios of suicidality in a large Huntington disease population compared with controls: marginal structural modeling of Enroll-HD registry data

    S. Reshef, V. Sung, G. Smith, O. Harari, D. Zhang, M. Forrest Gordon, R. Willock, R. Ribalov, J. Robles-Zurita, E. Furr Stimming (Parsippany-Troy Hills, USA)

    Objective: The aim of this study was to describe the risk of suicidality among individuals with versus those without Huntington disease (HD) from Enroll-HD. Background:…
  • 2023 International Congress

    Depression in Parkinson’s disease is associated with subcortical neurodegeneration and increased risk of all-cause mortality and dementia

    J. Badenoch, A. Paris, B. Jacobs, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)

    Objective: To evaluate the temporality, neuroanatomical correlates and prognostic significance of depression in PD using a large population cohort. Background: Depression may be an important…
  • 2022 International Congress

    The influence of GBA and LRRK2 on mood disorders in Parkinson’s Disease

    A. Thaler, N. Omer, B. Cohen, N. Giladi, M. Kestenbaum, J. Shirvan, J. Cedarbaum, M. Gana-Weisz, O. Goldstein, A. Orr-Urtreger, A. Mirelman (Tel-Aviv, Israel)

    Objective: To assess the influence of mutations in the LRRK2 and GBA genes on mood disorders among patients with Parkinson's disease (PD) Background: Mood disorders…
  • 2022 International Congress

    Parkinson’s disease caregiver burden in rural India

    S. Desai, D. Desai, I. Prashnani (Anand, India)

    Objective: To assess the caregiver burden and factors determining it in patients with PD. To assess the anxiety and depression amongst caregivers. Background: Patients with…
  • 2022 International Congress

    Association between thyroid dysfunction and severity of depression in de novo patients with Parkinson’s disease

    I. Sarac, H. Sarac, N. Henigsberg, F. Borovecki, L. Bagaric Krakan, I. Ivek, M. Iveta, T. Sukobljevic, Z. Kresic (Zagreb, Croatia)

    Objective: This study aimed to evaluate the association between thyroid disturbances and severity of depression in de novo PD patients Croatian residents. Background: Thyroid disease…
  • 2022 International Congress

    Depression and progression of motor symptoms in early stage of Parkinson’s disease

    YS. Hwang, SJ. Chung (Seoul, Republic of Korea)

    Objective: To investigate the association of depression with the progression of motor symptoms in patients with early-stage PD. Background: Depression is a major nonmotor symptom…
  • 2022 International Congress

    Parkinson’s Disease and Psychosocial Impact: Anxiety, Depression and Positive Symptoms

    O. Kaczmarek, S. Baek, A. Sethi, A. Stolarczyk, B. Bumstead, B. Anand, M. Buhse, M. Zarif, M. Gudesblatt (Patchogue, USA)

    Objective: Explore the relationship between patient self-reported assessment of positive symptoms, depression, and anxiety in PwPD. Background: Parkinson’s disease (PD) is a complex neurodegenerative disorder…
  • 2022 International Congress

    Childhood Trauma and Parkinson’s Disease: Associations of Adverse Childhood Experiences, Disease Severity and Quality of Life

    I. Subramanian, B. Mcdaniels, J. Farahnik, L. Mischley (Los Angeles, USA)

    Objective: Objective: The goal of this study was to survey individuals with PD to evaluate whether intensity of childhood trauma is associated with individual symptoms,…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25676 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley